| Abstrakt: |
A recent study conducted by researchers from the Second Affiliated Hospital of Xi'an Jiaotong University in China compared the effectiveness of two methods, chemiluminescent immunoassay (CLIA) and enzyme-linked immunosorbent assay (ELISA), in detecting phospholipase A2 receptor (PLA2R) autoantibodies in patients with primary membranous nephropathy (pMN). The study found that both CLIA and ELISA showed similar accuracy and consistency in detecting the autoantibodies. However, CLIA demonstrated a significant advantage in terms of automation and time-saving, particularly for smaller sample sizes. The researchers suggest that CLIA has the potential to become a preferred and widely adopted test in the future. [Extracted from the article] |
